Chapter 15: Lung: Chronic Diffuse Interstitial (Restrictive) Diseases Flashcards

1
Q

What is Chronic interstitial disease?

A

Chronic interstitial diseases are a heterogeneous group of disorders characterized
predominantly by inflammation and fibrosis of the pulmonary connective tissue, principally the
most peripheral and delicate interstitium
in thealveolar walls.

Many of the entities are of
unknown cause and pathogenesis,
some have anintra-alveolar as well as an interstitial
component,
and there isfrequent overlap in histologic features among the different conditions.
These disorders account for about 15% of noninfectious diseases seen by pulmonary
physicians.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

In general, the clinical and pulmonary functional changes of Chronic Diffuse Interstitial (Restrictive) Diseases are:

A

those of restrictive lung disease
(see the earlier discussion of obstructive versus restrictive pulmonary diseases).

Patients have
dyspnea, tachypnea, end-inspiratory crackles, and eventual cyanosis, without wheezing or
other evidence of airway obstruction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the classic Chronic Diffuse Interstitial (Restrictive) Diseases?

A

The classic physiologic features are reductions in carbon
monoxide diffusing capacity, lung volume, and compliance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why is Chronic Diffuse Interstitial (Restrictive) Diseases called infiltritative?

A

Chest radiographs show bilateral
infiltrative lesions in the form of small nodules, irregular lines,
orground-glass shadows, hence
the term infiltrative.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the circumstances in patients with Chronic infitritative ( restrictive) disease?

A

Eventually, secondary pulmonary hypertension and right-sided heart failure
with cor pulmonale may result.

Although the entities can often be distinguished in the early
stages.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why is hard to differentitate the advanced forms of Chronic Infiltrative ( Restrictive) Disease?

A

the advanced forms are hard to differentiate because they result in scarring and gross
destruction of the lung, often referred to as end-stage lung or honeycomb lung

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How do you categorized Chronic infiltrative ( restrictive) disease?

A

Diffuse
restrictive diseases are categorized based on histology and clinical features

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

TABLE 15-5 – Major Categories of Chronic Interstitial Lung Disease

A
  • FIBROSING
  • GRANULOMATOUS
  • EOSINOPHILIC
  • SMOKING RELATED
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

TABLE 15-5 – Major Categories of Chronic Interstitial Lung Disease

FIBROSING

A
  • Usual interstitial pneumonia (idiopathic pulmonary fibrosis)
  • Nonspecific interstitial pneumonia
  • Cryptogenic organizing pneumonia
  • Associated with connective tissue diseases
  • Pneumoconiosis
  • Drug reactions
  • Radiation pneumonitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

TABLE 15-5 – Major Categories of Chronic Interstitial Lung Disease

GRANULOMATOUS

A
  • Sarcoidosis
  • Hypersensitivity pneumonitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

TABLE 15-5 – Major Categories of Chronic Interstitial Lung Disease

SMOKING RELATED

A
  • Desquamative interstitial pneumonia
  • Respiratory bronchiolitis-associated interstitial lung disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is Idiopathic Pulmonary Fibrosis?

A

The term idiopathic pulmonary fibrosis (IPF) refers to a clinicopathologic syndrome with
characteristic radiologic, pathologic, and clinical features.

**In Europe the term cryptogenic
fibrosing alveolitis
is more popular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the other name of Idiopathic Pulmonary Fibrosis ?

A

cryptogenic fibrosing alveolitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The histologic pattern of fibrosis is referred to as __________, which is required for the diagnosis of IPF but can also be seen in
other diseases
,notably connective tissue diseases, chronic hypersensitivity pneumonia, and
asbestosis.

A
usual
interstitial pneumonia (UIP)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The International Multidisciplinary Consensus Classification is an excellent
reference for definitions and understanding of idiopathic interstitial pneumonias

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the pathogenesis of IPF?

A

The earlier view was that IPF is initiated by an
unidentified insult
thatgives rise to chronic inflammation resulting in fibrosis.

The dismal failure
of potent anti-inflammatory therapy in altering the course of the disease did not support this
view.

The current concept is that IPF is caused by “repeated cycles” of epithelial
activation/injury by some unidentified agent
.

There is inflammation and induction of TH2 type T
cell response characterized by the presence of eosinophils, mast cells, IL-4 and IL-13 in the
lesions.

But the significance of this inflammatory response is unknown.

Abnormal epithelial
repair at these sites gives rise to exuberant fibroblastic/myofibroblastic proliferation
, leading to
the “fibroblastic foci” that are so characteristic of IPF ( Fig. 15-13 ).

The circuits that drive such
aberrant epithelial repair are not fully understood, but all evidence points to TGF-β1 as the
driver of the process.

TGF-β1 is known to be fibrogenic and is released from injured type I
alveolar epithelial cells
( Fig. 15-13 ).

It favors the transformation of fibroblasts into
myofibroblasts and deposition of collagen and other extracellular matrix molecules.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are fibroblastic foci that are so characteristic of IPF?

A

Abnormal epithelial
repair
at these sites gives rise toexuberant fibroblastic/myofibroblastic proliferation, leading to
the “fibroblastic foci” that are so characteristic of IPF ( Fig. 15-13 ).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

In IPF, though the aberrant epithelial repair isnt fully understood, where does all the evidence of pathology point to?

A

The circuits that drive such
aberrant epithelial repair are not fully understood, but all evidence points to TGF-β1 as the
driver of the process.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is TGF- B1?

A

TGF-β1 is known to be fibrogenic and is released from injured type I alveolar epithelial cells ( Fig. 15-13 ).

  • *It favors the transformation of fibroblasts** into
  • *myofibroblasts and deposition of collagen** and other extracellular matrix molecules.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q
A

FIGURE 15-13 Schematic representation of current understanding of the pathogenesis of
idiopathic pulmonary fibrosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the two molecules regulated by TGF-β1?

A
  • telomerase activity
  • caveolin-1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the relation of telomerase shortening in IPF?

A

The concept that there is an intrinsic abnormality of tissue repair in IPF is supported by the
finding that some patients with familial pulmonary fibrosis have mutations that shorten
telomeres.

Recall that telomeres control cell replications (see Chapters 1 and 7 and with

  • *shortening of telomeres alveolar epithelial cells undergo rapid senescence and
    apoptosis. **[56,] [57]

Interestingly, TGF-β1 negatively regulates telomerase activity , thus
facilitating epithelial cell apoptosis and the cycle of death and repair.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What does caveolin- 1 does?

A

Another molecule
regulated by TGF-β1 is caveolin-1, the predominant structural protein of caveolae, flaskshaped
invaginations of the plasma membrane present in many terminally differentiated cells.

Caveolin-1 acts as an endogenous inhibitor of pulmonary fibrosis by limiting TGF-β1–induced
production of extracellular matrix and restoring alveolar epithelial repair processes.

Caveolin-1
is decreased in epithelial cells and fibroblasts of IPF patients, and overexpression of caveolin-1
in a mouse model limits fibrosis. [59]

Such down-regulation may be mediated by the ability of TGF-β1 to attenuate the expression of caveolin-1 in fibroblasts.

Thus, it seems that TGF-β1
has its fingerprints on multiple pathways that regulate pulmonary fibrosis.

Therapeutics directed
toward neutralizing TGF-β1, enhancing telomerase activity or delaying telomere shortening, or
augmenting caveolin-1 may lead to novel treatments for IPF in the future.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the macroscopic appearance of IPF?

A

Grossly, the pleural surfaces of the lung are cobblestoned as a result of the
retraction of scars along the interlobular septa.

The cut surface shows fibrosis (firm, rubbery
white areas)
of thelung parenchyma with lower-lobe predominanceanda distinctive
distribution in the subpleural regions and along the interlobular septa.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
In IPF the predominance of fibrosis is on the\_\_\_\_\_\_ and with a distinctive distribution where?
The cut surface shows fibrosis (firm, rubbery white areas) of the lung parenchyma with **lower-lobe predominance** and a ***distinctive*** ***distribution in the subpleural regions and along the interlobular septa.***
26
What is the microscopic appearance of IPF?
Microscopically, the hallmark of UIP is ***patchy interstitial fibrosis***, which **varies in intensity ( Fig. 15-14 ) and age.**
27
What is the contents of the earliest lesion in IPF?
**The earliest lesions contain *exuberant fibroblastic proliferation (fibroblastic foci).*** With time these areas become more collagenous and less cellular**.** **Quite typical is the coexistence of both early and late lesions ( Fig. 15-15 ).** **The *dense fibrosis causes the destruction of alveolar architecture and formation of cystic spaces lined by hyperplastic type II pneumocytes or bronchiolar epithelium (honeycomb fibrosis)***
28
With adequate sampling, **these diagnostic histologic changes**(i.e.,**areas of dense collagenous fibrosis with relatively normal lung and fibroblastic foci**)**can be identified even in advanced IPF.** T or F
True **There is mild to moderate** **inflammation within the fibrotic areas,** consisting of **mostly lymphocytes, and a few plasma cells, neutrophils, eosinophils, and mast cells**. Foci of squamous metaplasia and smooth muscle hyperplasia may be present. Pulmonary arterial hypertensive changes (intimal fibrosis and medial thickening) are often present. In acute exacerbations diffuse alveolar damage is superimposed on the UIP pattern
29
FIGURE 15-14 Usual interstitial pneumonia. The fibrosis is more pronounced in the subpleural region.
30
FIGURE 15-15 Usual interstitial pneumonia. Fibroblastic focus with fibers running parallel to surface and bluish myxoid extracellular matrix. **Honeycombing is present on the left.**
31
What is the clinical course of IPF?
IPF **begins insidiously**, with **gradually increasing dyspnea on exertion** and **dry cough.** Most patients are **40 to 70 years** old at the time of presentation. **Hypoxemia, cyanosis, and clubbing occur late in the course.** The progression in an individual patient is unpredictable. Most patients have a **gradual deterioration of their pulmonary status, despite medical treatment (steroids, cyclophosphamide, or azathioprine)**. In some IPF patients, there are **acute exacerbations of the underlying disease**with a**rapid downhill clinical course**. The **mean survival is 3 years** or less. Lung transplantation is the only definitive therapy currently available.
32
What is the only definitive treatment for IPF?
**Lung transplantation** is the only definitive therapy currently available.
33
What is Nonspecific Interstitial Pneumonia?
The concept of nonspecific interstitial pneumonia (NSIP) emerged when it was realized that **there is a group of patients with diffuse interstitial lung disease of unknown etiology whose lung biopsies fail to show diagnostic features of any of the other well-characterized interstitial diseases.** Despite its “nonspecific” name, NSIP has **distinct radiologic and histologic features and is important to recognize, since these patients have a much better prognosis than do those with UIP**
34
Which has a better prognosis. IUP or NSIP?
Despite its “nonspecific” name, **NSIP** has distinct radiologic and histologic features and is important to recognize, since these patients have a **much better prognosis** than do those with UIP.
35
Morphology. On the basis of its histology, NSIP is divided into \_\_\_\_\_\_\_\_\_\_\_\_.
* cellular and * fibrosing patterns
36
What is the cellular pattern of the NSIP?
The cellular pattern ***consists primarily of mild to moderate chronic interstitial inflammation***, containing ***lymphocytes and a few plasma cells, in a uniform or patchy*** ***distribution.***
37
What is the fibrosing pattern of the NSIP?
What is the cellular pattern of the NSIP? The fibrosing pattern **consists of diffuse or patchy interstitial fibrosis *without the temporal heterogeneity that is characteristic of UIP***. * **Fibroblastic foci and honeycombing are absent. *** However, in s***ome patients both NSIP and UIP patterns can be seen in different areas of the lung;*** the prognosis in these is the same as for UIP
38
Fibroblastic foci and honeycombing are present in NSIP? t or F
False
39
What is the Clinical Course NSIP?
Patients **present with dyspnea and cough** of several months' duration. They are typically between **46 and 55 years of age.** Those having the NSIP cellular pattern are **somewhat younger than those with the fibrosing pattern or UIP.** **Patients with the cellular pattern have a better outcome**than do those with fibrosing pattern and UIP
40
What is Cryptogenic Organizing Pneumonia?
Cryptogenic organizing pneumonia is synonymous with the popular term ***bronchiolitis obliterans organizing pneumonia;***however, the**former is now preferred,****since it conveys the essential features of a clinicopathologic syndrome**of unknown**etiology and avoids confusion with airway diseases such as bronchiolitis obliterans.** ## Footnote **Patients present with cough and dyspnea and have subpleural or peribronchial patchy areas of airspace consolidation radiographically**
41
What is the histologic appearance of cryptogenic organizing pneumonia?
Histologically, **cryptogenic organizing pneumonia** is characterized by the **presence of polypoid** **plugs of loose organizing connective tissue *(******Masson bodies)*****within alveolar ducts, alveoli** ( Fig. 15-16 ), and often bronchioles. The **connective tissue is all of the same age,** and the **underlying** **lung architecture is normal**. There is **no interstitial fibrosis or honeycomb lung**. Some patients recover spontaneously, but **most need treatment with oral steroids for 6 months or longer for** **complete recovery.**
42
What are Masson Bodies?
presence of **polypoid** **plugs of loose organizing connective tissue** (Masson bodies)
43
FIGURE 15-16 Cryptogenic organizing pneumonia. Some alveolar spaces are filled with balls of fibroblasts (Masson bodies), while the alveolar walls are relatively normal. A, Low power; B, high power
44
It is important to recognize that organizing pneumonia with **intra-alveolar fibrosis** is also often **seen as a response to infections or inflammatory injury of the lungs**. [66] These **include viral and bacterial pneumonia, inhaled toxins, drugs, connective tissue disease, and graft-versushost disease in bone marrow transplant recipient**s. The prognosis for these patients is the same as that for the underlying disorder.
45
What is Pulmonary Involvement in Connective Tissue Diseases?
Many connective tissue diseases, notably **systemic lupus erythematosus, rheumatoid arthritis, progressive systemic sclerosis (scleroderma), dermatomyositis-polymyositi**s, and mixed **connective tissue disease,** ***can involve the lung to a lesser or greater degree at some time in their course.*** Pulmonary involvement can occur in different patterns; ***NSIP, UIP (similar to that seen in IPF), vascular sclerosis, organizing pneumonia, and bronchiolitis*** are the most common.
46
Many connective tissue diseases, notably\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_, can involve the lung to a lesser or greater degree at some time in their course.
* systemic lupus erythematosus, * rheumatoid arthritis, * progressive systemic sclerosis (scleroderma), * dermatomyositis-polymyositis, and * mixed connective tissue disease
47
In the pulmonary involvement in Connective tissue diseases, what are the patterns?
Pulmonary involvement can occur in different patterns; * **NSIP, UIP (similar to that** **seen in IPF),** * **vascular sclerosis,** * **organizing pneumonia,** * **and bronchiolitis** **​** are the most common
48
Rheumatoid arthritis: pulmonary involvement may occur in 30% to 40% of patients as
* (1) chronic pleuritis, with or without effusion; * (2) diffuse interstitial pneumonitis and fibrosis; * (3) intrapulmonary rheumatoid nodules; or * (4) pulmonary hypertension
49
What is the more common pattern in Systemic sclerosis?
• Systemic sclerosis (scleroderma): **diffuse interstitial fibrosis** (NSIP pattern more common than UIP)
50
What is the more common pattern in Lupus erythematosus?
• Lupus erythematosus: patchy, transient parenchymal infiltrates, and occasionally severe lupus pneumonitis
51
Pulmonary involvement in these diseases is usually **associated with a variable prognosis**, partly dependent on the type of pulmonary disease, although it **is still better than that of idiopathic UIP**
52
What is pneumoconiosis?
The term pneumoconiosis was originally coined to describe th**e non-neoplastic lung reaction** to **inhalation of mineral dusts** encountered in the **workplace**. Now it **also includes diseases induced by organic as well as inorganic particulates**and**chemical fumes and vapors**. A simplified classification is presented in Table 15-6 . Regulations limiting worker exposure have resulted in a marked decrease in dust-associated diseases.
53
TABLE 15-6 -- Lung Diseases Caused by Air Pollutants
* MINERAL DUSTS * ORGANIC DUSTS THAT INDUCE HYPERSENSITIVITY PNEUMONITIS * ORGANIC DUSTS THAT INDUCE ASTHMA * CHEMICAL FUMES AND VAPORS
54
TABLE 15-6 -- Lung Diseases Caused by Air Pollutants MINERAL DUSTS
* Coal dust * Silica * Asbestos * Beryllium * Iron oxide * Barium sulfate * Tin oxide
55
TABLE 15-6 -- Lung Diseases Caused by Air Pollutants ORGANIC DUSTS THAT INDUCE HYPERSENSITIVITY PNEUMONITIS
* Moldy hay * Bagasse * Bird droppings
56
TABLE 15-6 -- Lung Diseases Caused by Air Pollutants ORGANIC DUSTS THAT INDUCE ASTHMA
* Cotton, flax, hemp * Red cedar dust
57
TABLE 15-6 -- Lung Diseases Caused by Air Pollutants CHEMICAL FUMES AND VAPORS
* Nitrous oxide, * sulfur dioxide, * ammonia, * benzene, * insecticides
58
What are the diseases caused by Coal dust?
* Anthracosis Coal mining (particularly hard coal) * Macules * Progressive massive fibrosis * Caplan syndrome
59
What are the diseases caused by Silica ?
* Silicosis * Caplan syndrome
60
What are the diseases caused by Asbestos ?
* Asbestosis * Pleural plaques * Caplan syndrome * ***Mesothelioma*** * **Carcinoma of the lung, larynx, stomach, colon**
61
What are the Lung Diseases Caused by **Beryllium?**
* Acute berylliosis * Beryllium granulomatosis * Lung carcinoma
62
What are the Lung Diseases Caused byIron oxide?
Siderosis Exposure Welding
63
What is the lung disease caused by Barium sulfate?
Baritosis Which is an exposure from mining?
64
What is the lung disease caused by Tin oxide?
Stannosis Exposure from Mining
65
What is the lung disease caused by Moldy hay?
Farmer's lung from farming
66
What is the lung disease caused by Bagasse?
Bagassosis from Manufacturing wallboard, paper
67
What is the lung disease caused by Bird droppings?
Bird-breeder's lung From Bird handling
68
What is the lung disease caused by Cotton, flax, hemp?
Byssinosis
69
What is the lung disease caused by Red cedar dust?
70
What is the lung disease caused by Nitrous oxide, sulfur dioxide, ammonia, benzene, insecticides?
* Bronchitis, asthma * Pulmonary edema * ARDS * Mucosal injury * Fulminant poisoning From occupational and accidental exposure
71
Although the pneumoconioses result from well-defined occupational exposure to specific airborne agents, particulate air pollution also has deleterious effects on the general population, especially in urban areas. Studies have found increased morbidity (e.g., asthma incidence) and mortality rates in populations that are exposed to high ambient air particulate levels, [68,] [69] leading to calls for greater efforts to reduce the levels of particulates in urban air
72
The development of a pneumoconiosis depends on
(1) the **amount of dust retaine**d in the lung and airways; (2) the **size, shape, and therefore buoyanc**y of the particles; (3) **particle solubility** and physiochemical reactivity; and (4) the **possible additional effects of other irritants** (e.g., concomitant tobacco smoking).
73
The amount of dust retained in the lungs is **determined by :**
**the dust concentration in ambient air,** the **duration of exposure, and the effectiveness of clearance mechanisms.** Any influence, such as **cigarette smoking,** that affects the integrity of the mucociliary apparatus significantly predisposes to the accumulation of dust.
74
The most dangerous particles range from \_\_\_\_\_\_\_- in diameter **because they may reach the terminal small airways and air sacs and settle in their linings.**
1 to 5 μm Under normal conditions there is a **small pool of intra-alveolar macrophages**, and this is expanded by **recruitment of more macrophages** when **dust reaches the alveolar spaces**. The protection provided by phagocytosis of particles, however, can be overwhelmed by a large dust burden by specific chemical interactions of the particles with cells.
75
The solubility and cytotoxicity of particles , which are influenced to a considerable extent by **their size**, **modify the nature of the pulmonary response.** In general, the smaller the particle, the **more likely it is to appear in the pulmonary fluids and reach toxic levels rapidly, depending, of course, on the solubility of the agent.** **T or F**
True Therefore, **smaller particles tend to cause acute lung injury.** Larger particles resist dissolution and so may persist within the lung parenchyma for years. **These tend to evoke fibrosing collagenous pneumoconioses**, such as is characteristic of silicosis. Some of the particles may be taken up by epithelial cells or may cross the epithelial cell lining and interact directly with fibroblasts and interstitial macrophages. Some may reach the lymphatics by direct drainage or within migrating macrophages and thereby initiate an immune response to components of the particulates or to self-proteins modified by the particles or both. This response amplifies the intensity and the duration of the local reaction. Although tobacco smoking worsens the effects of all inhaled mineral dusts, the effects of asbestos are particularly magnified by smoking. The effects of inhaled particles are not confined to the lung alone, since solutes from particles can enter the blood and lung inflammation invokes systemic responses
76
In general, only a small percentage of exposed people develop occupational respiratory diseases, **implying a genetic predisposition to their development.** [71] In one study, genetic variation of serum and erythrocytic proteins was shown to correlate with susceptibility to developing silicosis, chronic bronchitis, and occupational asthma. [72] Many of the diseases listed in Table 15-6 are quite uncommon. Hence only a selected few that cause fibrosis of the lung are presented next.
77
What is Coal Workers' Pneumoconiosis? Dust reduction measures in coal mines around the globe have drastically reduced the incidence of coal workers' pneumoconiosis (CWP). The spectrum of lung findings in coal workers is wide, varying from
* (1) asymptomatic anthracosis to * (2) simple CWP with little to no pulmonary dysfunction to * (3) complicated CWP, or progressive massive fibrosis (PMF), in which lung function is compromised. [73]
78
What is the pathogenesis of CWP?
The pathogenesis of complicated CWP, particularly what causes the **lesions of simple CWP to progress to PMF,** is **incompletely understood**. Contaminating silica in the coal dust can favor progressive disease. In most cases**, carbon dust itself is the major** **culprit**, and studies have shown that complicated lesions contain much more dust than simple lesions.
79
What is anthracosis?
. Anthracosis is the **most innocuous coal-induced pulmonary lesion** in coal **miners and is also seen to some degree in urban dwellers and tobacco smokers**. Inhaled carbon pigment is engulfed by alveolar or interstitial macrophages, which then accumulate in the connective tissue along the lymphatics, including the pleural lymphatics, or in organized lymphoid tissue along the bronchi or in the lung hilus.
80
Simple CWP is characterized by:
Simple CWP is characterized by **coal macules (1 to 2 mm in diameter)** and the **somewhat** **larger coal nodules**. The coal macule **consists of carbon-laden macrophages**; the **nodule** **also contains small amounts** of a delicate network of collagen fibers. Although these lesions are scattered throughout the lung, the **upper lobes and upper zones of the lower lobes are** **more heavily involved**.
81
Simple CWP is primiary located where?
They are located primarily adjacent to respiratory bronchioles, the **site of initial dust accumulation**. In due course dilation of adjacent alveoli occurs, a condition sometimes referred to as **centrilobular emphysema.**
82
What is Complicated CWP?
``` Complicated CWP (progressive massive fibrosis) **occurs on a background of simple CWP** and **generally requires many years to develop**. ``` It is **characterized by intensely blackened scars larger than 2 cm**,**sometimes up to 10 cm**in**greatest diamete**r. They are usually multiple ( Fig. 15-17 ). Microscopically the lesions consist of dense collagen and pigment. The **center of the lesion is often necrotic**, **most likely due to local ischemia.**
83
FIGURE 15-17 Progressive massive fibrosis superimposed on coal workers' pneumoconiosis. The large, blackened scars are located principally in the upper lobe. Note the extensions of scars into surrounding parenchyma and retraction of adjacent pleura.
84
CWP is usually a benign disease that causes little decrement in lung function. T or F
True
85
Even mild forms of complicated CWP fail to demonstrate abnormalities of lung function. In a minority of cases (fewer than 10%), PMF develops, leading to increasing pulmonary dysfunction, pulmonary hypertension, and cor pulmonale. Once PMF develops, it may become progressive even if further exposure to dust is prevented. ``` Unlike silicosis (discussed later), there is no convincing evidence that coal dust increases susceptibility to tuberculosis. ``` There is some evidence that exposure to coal dust increases the incidence of chronic bronchitis and emphysema, independent of smoking. Thus far, however, there is no compelling evidence that CWP in the absence of smoking predisposes to cancer.
86
What is Silicosis?
Silicosis is a **lung disease caused by inhalation of crystalline silicon dioxide** (silica). [74] Currently the most prevalent chronic occupational disease in the world , **silicosis usually** **presents after decades of exposure as a slowly progressing, nodular, fibrosing pneumoconiosis.** As shown in Table 15-6 , workers in a large number of occupations are at risk, especially sandblasters and many mine workers . Less commonly, heavy exposure over months to a few years can result in acute silicosis, a disorder **characterized by the accumulation of abundant** **lipoproteinaceous material within alveoli (identical morphologically to alveolar proteinosis,** which is discussed later).
87
Currently what is the **most prevalent chronic occupational disease** in the world?
Currently the most prevalent chronic occupational disease in the world , **silicosis usually** **presents after decades of exposure as a slowly progressing, nodular, fibrosing pneumoconiosis.**
88
Silica occurs in both crystalline and amorphous forms, but crystalline forms (including quartz, crystobalite, and tridymite) are much more fibrogenic. Of these, what is the most implicated of these in silicosis?
Of these, quartz is most commonly implicated in silicosis.
89
What is the pathophysiology of silicosis?
After inhalation, the **particles interact with epithelial cells and macrophages.** Within the macrophages **silica causes activation** and release of mediators . Such mediators include **IL-1, TNF, fibronectin, lipid mediators, oxygen-derived free radicals,** and **fibrogenic cytokines**. [75,] [76] Especially compelling is evidence incriminating TNF, since anti-TNF monoclonal antibodies can block lung collagen accumulation in mice given silica intratracheally. It has been noted that when mixed with other minerals, quartz has a reduced fibrogenic effect. This phenomenon is of practical importance because quartz in the workplace is rarely pure. Thus, miners of the iron-containing ore hematite may have more quartz in their lungs than some quartz-exposed workers and yet have relatively mild lung disease because the hematite somehow provides a protective effect. Although amorphous silicates are biologically less active than crystalline silica, heavy lung burdens of these minerals may also produce lesions.
90
What is the characteristic of Silicosis in early phase?
Silicosis is characterized grossly in its early stages by t**iny, barely palpable, discrete pale to blackened** (if coal dust is also present) **nodules in the upper zones of the lungs**
91
What happens as the Silicosis progress?
As the disease progresses, **these nodules may coalesce into hard, collagenous** **scars** ( Fig. 15-18 ). Some nodules **may undergo central softening and cavitation.** This change **may be due to superimposed tuberculosis or to ischemia.** **Fibrotic lesions may also** **occur in the hilar lymph nodes and pleura**. Sometimes, **thin sheets of calcification occur in the** **lymph nodes and are seen radiographically as eggshell calcification** (i.e., calcium surrounding a zone lacking calcification).
92
What is eggshell calcification?
In Silicosis, **fibrotic lesions may also occur in the hilar lymph nodes and pleura**. Sometimes, **thin sheets of calcification occur in the lymph nodes and are seen radiographically as eggshell calcification**(i.e.**, calcium surrounding a zone lacking calcification).** If the disease continues to progress, expansion and coalescence of lesions may produce progressive massive fibrosis.
93
What is the hitologic apperance in Silicosis?
Histologic examination reveals that the **nodular lesions consist of concentric layers of hyalinized collagen surrounded** **by a dense capsule of more condensed collagen** ( Fig. 15-19 ) . Examination of the nodules by polarized microscopy **reveals the birefringent silica particles**
94
FIGURE 15-18 Advanced silicosis (transected lung). Scarring has contracted the upper lobe into a small dark mass (arrow). Note the dense pleural thickening
95
FIGURE 15-19 Several coalescent collagenous silicotic nodules.
96
What is the chest xray appearance of SIlicosis?
Chest radiographs typically show a **fine nodularity in the upper zones of the lung**, but **pulmonary functions are either normal or only moderately affected**. **Most patients do not develop shortness of breath until late in the course**, after progressive massive fibrosis is present.
97
Silicosis may be progressive **even if the patient is no longer exposed.** T or F
True The disease may be progressive even if the patient is no longer exposed. The disease is slow to kill, but impaired pulmonary function may severely limit activity.
98
What Lung Diseases Caused by Air Pollutants is associated with inc susceptibility to tb?
* **Silicosis is associated with an increased*** * **susceptibility to tuberculosis.*** It is postulated that silicosis results in a depression of cellmediatedimmunity, and crystalline silica may inhibit the ability of pulmonary macrophages to kill phagocytosed mycobacteria. **Nodules of silicotuberculosis often display a central zone of caseation.** The relationship between silica and lung cancer is contentious. In 1997, the International Agency for Research on Cancer (IARC) concluded that crystalline silica from occupational sources is carcinogenic in humans. However, this subject continues to be controversial.
99
Nodules of silicotuberculosis often display a \_\_\_\_\_\_\_\_\_-
central zone of caseation.
100
Asbestos is a family of crystalline hydrated silicates that form fibers. Use of asbestos is seriously restricted in many developed countries; however, there is little, if any, control in less developed parts of the world. [77] On the basis of epidemiologic studies, occupational exposure to asbestos is linked to
* Localized fibrous plaques or, rarely, diffuse pleural fibrosis * Pleural effusions * Parenchymal interstitial fibrosis (asbestosis) * Lung carcinoma * Mesotheliomas * Laryngeal and perhaps other extrapulmonary neoplasms, including colon carcinomas
101
An increased incidence of asbestos-related cancer in family members of asbestos workers has alerted the general public to the potential hazards of asbestos in the environment. The proper public health policy toward low-level exposures that might be encountered in old buildings or schools is unsettled: some experts question the wisdom of expensive asbestos abatement programs for environments with airborne fiber counts that are as much as 100-fold lower than allowed by occupational standards
102
What dictates whether Asbestos can cause disease?
Concentration, size, shape, and solubility of the different forms of asbestos dictate whether it causes disease
103
There are two distinct geometric forms of asbestos: \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_.
* serpentine and * amphibole
104
Serpentine form of Asbestos account for?
The serpentine chrysotile chemical form accounts for most of the asbestos used in industry.
105
What form of Asbestos are more pathogenic than chrysotiles particularly with respect to induction of malignant pleural tumors (mesotheliomas)?
***Amphiboles,*** even though less prevalent, are more pathogenic than chrysotiles particularly with respect to induction of malignant pleural tumors (mesotheliomas). \*\*\*BOARD EXAM Q
106
The greater pathogenicity of amphiboles is apparently related to their \_\_\_\_\_\_\_\_\_\_\_\_\_.
aerodynamic properties and solubility
107
Why is Chrysotiles are likely to become impacted in the upper respiratory passages and removed by the mucociliary elevator?
Chrysotiles, with their **more flexible, curled structure,** are likely to become impacted in the upper respiratory passages and removed by the mucociliary elevator. Furthermore, once trapped in the lungs, **chrysotiles are gradually leached from the tissues because they are more soluble than amphiboles.**
108
What is the reason why amphiboles penetrate epithelial cells and reach the interstitium?
In contrast, the **straight, stiff** amphiboles may **align themselves in the airstream** and thus be delivered deeper into the lungs, where they can penetrate epithelial cells and reach the interstitium.
109
**Both amphiboles and serpentines are fibrogenic,**and increasing doses are associated with a higher incidence of all asbestos-related diseases **except mesothelioma**, **which is only associated with amphibole exposure.** T or F
True
110
In contrast to other inorganic dusts**, asbestos can also act as a tumor initiator and promoter.** **T or F**
True Some of its oncogenic effects are mediated by reactive free radicals generated by asbestos fibers, which preferentially localize in the distal lung, **close to the mesothelial layers.** Potentially toxic chemicals adsorbed onto the asbestos fibers most likely contribute to the oncogenicity of the fibers. For example, the adsorption of carcinogens in tobacco smoke onto asbestos fibers may well contribute to the remarkable synergy between tobacco smoking and the development of lung carcinoma in asbestos workers. One study of asbestos workers found a ***fivefold increase of lung carcinoma with asbestos exposure alone,***while asbestos exposure and **smoking together led to a 55-fold increase in the risk of lung cancer**
111
The occurrence of asbestosis, like the other pneumoconioses**, depends on the interaction of inhaled fibers with lung macrophages and other parenchymal cells**. What is the pathogenesis?
The **initial injury occurs at bifurcations of small airways and ducts,**where the**asbestos fibers land and penetrate.** Macrophages, **both alveolar and interstitial, attempt to ingest and clear the fibers and are activated to release chemotactic factor**s and fibrogenic mediators that amplify the response. **Chronic deposition of fibers and persistent release of mediators eventually lead to generalized interstitial pulmonary inflammation and interstitial fibrosis.**
112
Asbestosis is marked by diffuse pulmonary interstitial fibrosis, which is indistinguishable from diffuse interstitial fibrosis resulting from other causes, e**xcept for the presence of multiple asbestos bodies.**
113
What is the appearance of Asbestos?
Asbestos bodies appear as golden brown, fusiform or beaded rods with a **translucent center and consist of asbestos fibers** **coated with an iron-containing proteinaceous material** ( Fig. 15-20 ). They arise when * *macrophages attempt to phagocytose asbestos fibers;** the **iron is presumably derived from** * *phagocyte ferritin.** Other inorganic particulates may become coated with similar iron-protein complexes and are called **ferruginous bodies** . Rare single asbestos bodies can be found in the lungs of normal people.
114
What are ferruginous bodies?
Asbestos bodies appear as golden brown, fusiform or beaded rods with a translucent center and consist of asbestos fibers coated with an **iron-containing proteinaceous materia**l ( Fig. 15-20 ). **They arise when macrophages attempt to phagocytose asbestos fibers**; the**iron is presumably derived from phagocyte ferritin.** Other inorganic particulates may become coated with similar iron-protein complexes and are called ferruginous bodies . Rare single asbestos bodies can be found in the lungs of normal people.
115
Asbestosis begins as \_\_\_\_\_\_\_\_\_\_\_
fibrosis around respiratory bronchioles and alveolar ducts and extends to involve adjacent alveolar sacs and alveoli. The fibrous tissue distorts the architecture, creating enlarged airspaces enclosed within thick fibrous walls; **eventually the affected regions become honeycombed.**
116
The pattern of fibrosis in asbestosis is **similar to that seen in UIP**, with fibroblastic foci and varying degrees of fibrosis, the **onlydifference being the presence of numerous asbestos bodies.** **T or F**
True
117
What is the difference in asbestosis compared to CWP and silicosis,
In contrast to CWP and silicosis, **asbestosis begins in the lower** **lobes and subpleurally.** The **middle and upper lobes of the lungs become affected as fibrosis** **progresses.** The **scarring may trap and narrow pulmonary arteries and arterioles, causing** **pulmonary hypertension and cor pulmonale.**
118
What is the most common manifestation of asbestos exposure?
**Pleural plaques**, the most common manifestation of asbestos exposure, **are wellcircumscribed plaques of dense collagen**( Fig. 15-21 ), often**containing calcium**. They **develop most frequently on the anterior and posterolateral aspects of the parietal pleura and over the domes of the diaphragm.** The **size and number of pleural plaques do not correlate with the level of exposure to asbestos or the time since exposure**. [81] **They do not contain asbestos bodies;**however,**only rarely do they occur in individuals who have no history or evidence of asbestos exposure.** Uncommonly, asbestos exposure induces pleural effusions, which are usually serous but may be bloody. Rarely, diffuse visceral pleural fibrosis may occur and, in advanced cases, bind the lung to the thoracic cavity wall.
119
**Both lung carcinomas and mesotheliomas (pleural and peritoneal) develop in workers exposed to asbestos** **T or F**
**T** **Both lung carcinomas and mesotheliomas (pleural and peritoneal) develop in workers exposed to asbestos.** The risk of lung carcinoma is increased about fivefold for asbestos workers; the relative risk of mesotheliomas, normally a rare tumor (2 to 17 cases per 1 million persons), is more than 1000-fold greater. Concomitant cigarette smoking greatly increases the risk of lung carcinoma but not that of mesothelioma.
120
``` FIGURE 15-20 High-power detail of an asbestos body, revealing the typical beading and knobbed ends (arrow). ```
121
FIGURE 15-21 Asbestos-related pleural plaques. Large, discrete fibrocalcific plaques are seen on the pleural surface of the diaphragm
122
``` The clinical findings in asbestosis are very similar to those caused by other diffuse interstitial lung diseases (discussed earlier). ``` What is the first manifestation?
Dyspnea is usually the first manifestation; at first, it is **provoked by exertion**, **but later it is present even at rest.** The dyspnea is usually accompanied **by a cough associated with production of sputum.** These manifestations rarely appear fewer than 10 years after first exposure and are more common after 20 years or more.
123
Chest x rays of abestosis reaveal?
Chest x-rays reveal irregular linear densities, particularly in both lower lobes.
124
With advancement of the pneumoconiosis, ___________ develops.
a honeycomb pattern The disease may remain static or progress to respiratory failure, cor pulmonale, and death. **Pleural plaques are usually asymptomati**c and are **detected on radiographs as circumscribed densities.** Asbestosis complicated by lung or pleural cancer is associated with a particularly grim prognosis.
125
Drug-Induced Lung Diseases. Drugs can cause a **variety of both acute and chronic alterations in respiratory structure and function, interstitial fibrosis, bronchiolitis obliterans, and eosinophilic pneumonia** ( Table 15-7 ). [82] For example, \_\_\_\_\_\_\_\_\_\_\_cause pulmonary damage and fibrosis as a result of direct toxicity of the drug and by stimulating the influx of inflammatory cells into the alveoli.
cytotoxic drugs used in cancer therapy (e.g., bleomycin)
126
\_\_\_\_, a **drug used to treat cardiac arrhythmias,** preferentially concentrated in the lung and **causes significant pneumonitis in 5% to 15% of patients receiving it.**
Amiodarone
127
TABLE 15-7 -- Examples of Drug-Induced Pulmonary Disease Bleomycin
Pneumonitis and fibrosis
128
TABLE 15-7 -- Examples of Drug-Induced Pulmonary Disease Methotrexate
Hypersensitivity pneumonitis
129
TABLE 15-7 -- Examples of Drug-Induced Pulmonary Disease Amiodarone
Pneumonitis and fibrosis
130
TABLE 15-7 -- Examples of Drug-Induced Pulmonary Disease Nitrofurantoin
Hypersensitivity pneumonitis
131
TABLE 15-7 -- Examples of Drug-Induced Pulmonary Disease What drugs cause Bronchospasm?
Aspirin β-Antagonists
132
What is Radiation pneumonitis?
Radiation pneumonitis is a well-known complication of therapeutic radiation of t**horacic tumors (lung, esophageal, breast, mediastinal).** [83] It **most often involves the lung within the radiation** port but occasionally may extend to other areas of the same lung or even the contralateral lung. It occurs in acute and chronic forms.
133
One to six months after fractionated irradiation,\_\_\_\_\_\_\_\_\_\_\_\_\_\_occurs in 10% to 20% of patients.
``` acute radiation pneumonitis (lymphocytic alveolitis or hypersensitivity pneumonitis) ``` It is manifest by fever, dyspnea out of proportion to the volume of lung irradiated, pleural effusion, and radiologic infiltrates that usually correspond to an area of previous irradiation. With steroid therapy, these symptoms may resolve completely in some patients without long-term effects, [84] while in others there is progression to chronic radiation pneumonitis (pulmonary fibrosis). The latter is a consequence of the repair of injured endothelial and epithelial cells within the radiation portal . Morphologic changes are those of diffuse alveolar damage, including severe atypia of hyperplastic type II cells and fibroblasts. **Epithelial cell atypia and foam cells within vessel walls are also characteristic of radiation damage.**
134
What are the morphologic changes of radiation induced pneumonitis?
. Morphologic changes are those of **diffuse alveolar damage, including severe atypia of hyperplastic type II cells and fibroblasts.**
135
What are also characteristic of radiation damage.
**Epithelial cell atypia and foam cells** within vessel walls are also characteristic of radiation damage.
136
What is sarcoidosis?
Sarcoidosis is a **systemic disease** of **unknown cause characterized by *noncaseating granulomas*** in many tissues and organs. Sarcoidosis **presents many clinical patterns**, but * **bilateral hilar lymphadenopathy or lung involvement is visible on chest radiographs in 90% of cases. *** Eye and skin lesions occur next in frequency. Since other diseases, including mycobacterial and fungal infections and berylliosis, can also produce noncaseating (hard) granulomas, the histologic diagnosis of sarcoidosis is made by exclusion. [85] The prevalence of sarcoidosis is **higher in women** than in men but varies widely in different countries and populations. In the United States the rates are **highest in the Southeast**; they are **10 times higher in American blacks than in whites**. In contrast, the d**isease is rare among Chinese and Southeast Asians.**
137
Sarcoidosis presents many clinical patterns, but 90% occurs on these two organs visible on chest radiograph.
bilateral hilar lymphadenopathy or lung involvement is visible on chest radiographs in 90% of cases.
138
Although the etiology of sarcoidosis remains unknown, several lines of evidence suggest that it is a **disease of disordered immune regulation in genetically predisposed individuals exposed to certain environmental agents.**[86] The role of each of these three contributory factors is summarized below.
* Immunological Factors. * Genetic Factors. * Environmental Factors.
139
There are several immunological abnormalities in the local milieu of sarcoid granulomas that suggest the development of a cell-mediated response to an unidentified antigen. [87] The process is driven by CD4+ helper T cells. These abnormalities include [88] :
* Intra-alveolar and interstitial accumulation of **CD4+ T cells, resulting in CD4/CD8 T-cellratios** ranging from **5 : 1 to 15 : 1**. There is oligoclonal expansion of T-cell subsets as determined by analysis of T-cell receptor rearrangement, suggesting an antigen-driven proliferation. * **Increased levels of T cell–derived TH1** cytokines such as **IL-2 and IFN-γ,** resulting in Tcell expansion and macrophage activation, respectively. * **Increased levels of several cytokines in the local environment (IL-8, TNF, macrophage inflammatory protein 1α)** that favor recruitment of additional T cells and monocytes and contribute to the formation of granulomas. TNF in particular is released at high levels by activated alveolar macrophages, and the TNF concentration in the bronchoalveolar fluid is a marker of disease activity.
140
Additionally, there are systemic immunological abnormalities in individuals with sarcoidosis:
• Anergy to common skin test antigens such as Candida or tuberculosis purified protein **derivative (PPD)** • **Polyclonal hypergammaglobulinemia**, another **manifestation of helper T-cell** dysregulation.
141
Genetic Factors. Evidence of genetic influences are the familial and racial clustering of cases and the association with certain \_\_\_\_\_\_\_\_\_\_\_\_
HLA genotypes (e.g., HLA-A1 and HLA-B8).
142
These are possibly the most tenuous of all the associations in the pathogenesis of sarcoidosis.
Environment factors As with many other diseases of unknown etiology, suspicion falls on microbes. Indeed several putative microbes have been proposed as the inciting agent for sarcoidosis (e.g., mycobacteria, Propionibacterium acnes, and Rickettsia species). [89] Alas there is no unequivocal evidence that sarcoidosis is caused by an infectious agent
143
What is the histological apperance of sarcoidosis?
Histologically, all involved tissues show the ***classic well-formed noncaseating granulomas***( Fig. 15-22 ), each composed of an *aggregate of tightly clustered epithelioid cells,* **often with Langhans or foreign body–type giant cells.** **Central necrosis is unusual.** With chronicity the granulomas may become **enclosed within fibrous rims or may eventually be replaced by hyaline fibrous scars.** Laminated concretions composed of calcium and proteins known as **Schaumann bodies** and **stellate inclusions** known as **asteroid bodies** **enclosed within giant cells are found in approximately 60% of the granulomas.** **Though characteristic,** **these microscopic features** are ***notpathognomonic of sarcoidosis***, because asteroid and Schaumann bodies may be encountered in other granulomatous diseases (e.g., tuberculosis). Pathologic involvement of virtually every organ in the body has been cited at one time or another
144
What are **Schaumann bodies** and **stellate inclusions ?**
. **Laminated concretions composed of calcium and proteins known as Schaumann bodies**and**stellate inclusions known as asteroid bodies enclosed within giant cells are found in approximately 60% of the granulomas.** Though characteristic, these microscopic features are **notpathognomonic of sarcoidosi**s, because **asteroid and Schaumann bodies may be encountered in other granulomatous diseases (e.g., tuberculosis).** Pathologic involvement of virtually every organ in the body has been cited at one time or another
145
What is the common site of involvementi in sarcoidosis?
The **lungs are common sites of involvement**. [90] **Macroscopically there is usually no demonstrable alteration**, although in advanced cases**the coalescence of granulomas produces small nodules that are palpable or visible as 1 to 2 cm, noncaseating, noncavitated consolidations**. Histologically, the lesions are **distributed primarily along the lymphatics,** **around bronchi and blood vessels,** although alveolar lesions are also seen. The relative frequency of granulomas in the bronchial submucosa accounts for the **high diagnostic yield of bronchoscopic biopsies.** There **seems to be a strong tendency for lesions to heal in the lungs, so varying stages of fibrosis and hyalinization are often found.** The **pleural surfaces are sometimes involved**
146
In sarcoidosis Lymph nodes are involved in almost all cases, particularly the **hilar and mediastinal nodes,** **but any other node in the body may be involved.** Nodes are characteristically enlarged, discrete, and sometimes calcified. The tonsils are affected in about one quarter to one third of cases.
147
In Sarcoidosis, the spleen is affected microscopically in about three quarters of cases, but it is enlarged in only one fifth. On occasion, granulomas may coalesce to form small nodules that are barely visible macroscopically. The capsule is not involved. The liver is affected slightly less often than the spleen. It may also be moderately enlarged and contains scattered granulomas, more in portal triads than in the lobular parenchyma. **Needle biopsy can be diagnostic.**
148
The bone marrow is involved in about one fifth of cases of systemic sarcoidosis. The radiologically visible bone lesions have a particular tendency to involve phalangeal bones of the hands and feet, creating small circumscribed areas of bone resorption within the marrow cavity and a diffuse reticulated pattern throughout the cavity, with widening of the bony shafts or new bone formation on the outer surfaces
149
Skin lesions are encountered in one third to one half of cases. Sarcoidosis of the skin assumes a variety of macroscopic appearances (e.g., discrete subcutaneous nodules; focal, slightly elevated, erythematous plaques; or flat lesions that are slightly reddened and scaling, and resemble those of lupus erythematosus). Lesions may also appear on the mucous membranes of the oral cavity, larynx, and upper respiratory tract
150
The eye, its associated glands, and the salivary glands are **involved in about one fifth to one half of cases.** The ocular involvement takes the form of **iritis or iridocyclitis,** **either bilaterally or unilaterally.** Consequently, corneal opacities, glaucoma, and total loss of vision may occur. These ocular lesions are **frequently accompanied by inflammation of the lacrimal glands**, **with suppression of lacrimation**.
151
What is the Mikulicz syndrome?
**Bilateral sarcoidosis of the parotid, submaxillary, and sublingual glands** constitutes the combined **uveoparotid** involvement designated as Mikulicz syndrome
152
Muscle involvement is often underdiagnosed, since it may be asymptomatic . Muscle weakness, aches, tenderness, and fatigue should prompt consideration of occult sarcoid myositis. [91] Muscle biopsy can be useful for diagnosis when clinical features point to sarcoidosis. Sarcoid granulomas occasionally occur in the heart, kidneys, central nervous system, and endocrine glands, **particularly in the pituitary,** as well as in other body tissues.
153
Because of its varying severity and the inconstant distribution of the lesions, sarcoidosis is a **\_\_\_\_\_\_\_\_\_\_\_\_\_**
**protean clinical disease**. **It may be discovered unexpectedly** on **routine chest films as bilateral** **hilar adenopathy or may present with peripheral lymphadenopathy,** **cutaneous lesions, eye involvement**,**splenomegaly, or hepatomegaly**. In the great majority of cases, however, individuals seek medical attention because of the **insidious onset of respiratory abnormalities** **(shortness of breath, cough, chest pain, hemoptysis) or of constitutional signs and symptoms (fever, fatigue, weight loss, anorexia, night sweats).**
154
Sarcoidosis follows an unpredictable course characterized by either progressive chronicity or periods of activity interspersed with remissions, sometimes permanent, that may be spontaneous or induced by steroid therapy. Overall, **65% to 70% of affected patients recover with minimal or no residual manifestations**. Twenty percent have permanent loss of some lung function or some permanent visual impairment. Of the remaining **10% to 15%, some die of cardiac or central nervous system damage**, but most succumb to progressive pulmonary fibrosis and cor pulmonale
155
What is hypersensitivity pneumonitis?
The term **hypersensitivity pneumonitis** describes a **spectrum of immunologically mediated,** **predominantly interstitial, lung disorders caused by intense,** often prolonged exposure to inhaled **organic antigen**s. [92] Affected individuals have an **abnormal sensitivity or heightened reactivity to the antigen**, which,**in contrast to that occurring in asthma, involves primarily the alveoli (thus the synonym “allergic alveolitis”).** [93] It is important to recognize these diseases **early in their course because progression to serious chronic fibrotic lung disease** can be prevented by removal of the environmental agent.
156
What is the difference between hypersensitivy pneumonitis over asthma?
Affected individuals have an **abnormal sensitivity or heightened** **reactivity to the antigen**, which, **in contrast to that occurring in asthma, involves primarily the alveoli (thus the synonym *“allergic alveolitis”).***
157
Most commonly, hypersensitivity results from the **inhalation of organic dust containing antigens** made up of **spores of thermophilic bacteria, true fungi, animal proteins, or bacterial products.** Numerous specifically named syndromes are described, depending on the occupation or exposure of the individual. Farmer's lung results from exposure to dusts generated from harvested humid, warm hay that permits the rapid proliferation of the spores of thermophilic actinomycetes. **Pigeon breeder's lung (bird fancier's disease)** is provoked by proteins from serum, excreta, or feathers of birds. Humidifier or air-conditioner lung is caused by thermophilic bacteria in heated water reservoirs
158
Several lines of evidence suggest that hypersensitivity pneumonitis is an immunologically mediated disease:
* Bronchoalveolar lavage specimens obtained during the acute phase show increased levels of proinflammatory chemokines such as macrophage inflammatory protein 1α and IL-8. * Bronchoalveolar lavage specimens also consistently demonstrate increased numbers of T lymphocytes of both CD4+ and CD8+ phenotypes. * Most patients have specific antibodies in their serum, a feature that is suggestive of type III (immune complex) hypersensitivity. * Complement and immunoglobulins have been demonstrated within vessel walls by immunofluorescence, also indicating a type III hypersensitivity
159
Finally, the presence of noncaseating granulomas in two thirds of the patients with **hypersensitivity pneumonitis** suggests the development of a \_\_\_\_\_\_\_\_\_\_\_\_
T cell–mediated (type IV) delayed-type hypersensitivity against the implicated antigen(s).
160
Histologic changes in subacute and chronic forms are characteristically centered on bronchioles. [94] They include :
Histologic changes in subacute and chronic forms are characteristically centered on bronchioles. [94] They include * (1) **interstitial pneumonitis** consisting primarily of lymphocytes, plasma cells, and macrophages * (2) **noncaseating granulomas in two thirds of** **patients** ( Fig. 15-23 ); and * (3) **interstitial fibrosis, honeycombing**, and **obliterative bronchiolitis** **(in late stages)** *​* ​​ In more than half the patients there is also evidence of an intra-alveolar infiltrate.
161
FIGURE 15-23 Hypersensitivity pneumonitis, histologic appearance. Loosely formed interstitial granulomas and chronic inflammation are characteristic
162
What is the clinical manifestation of hypersensitivity pneumonitis?
The clinical manifestations are varied. Acute attacks, which follow inhalation of antigenic dust insensitized patients, **consist of recurring episodes of fever, dyspnea, cough, and leukocytosis.** * *Diffuse and nodular infiltrates appear in the chest radiograph, and pulmonary function tests** * *show an acute restrictive disorder** . Symptoms usually appear **4 to 6 hours after exposure** If exposure is continuous and protracted, a chronic form of the disease supervenes with progressive respiratory failure, dyspnea, and cyanosis and a decrease in total lung capacity and compliance—a picture similar to other forms of chronic interstitial disease.
163
What is PULMONARY EOSINOPHILIA ?
Several clinical and pathologic pulmonary entities are characterized by **an infiltration of** **eosinophils**, **recruited in part by elevated alveolar levels of eosinophil attractants such as IL-** **5.**
164
Pulmonary eosinophilia is divided into the following categories [96] :
* Acute eosinophilic pneumonia with **respiratory failure** * Simple pulmonary eosinophilia or **Löffler syndrome** * Tropical eosinophilia, caused by infection with **microfilariae** * **Secondary eosinophilia** (which occurs in a number of parasitic, fungal, and bacterial infections; in hypersensitivity pneumonitis; in drug allergies; and in association with asthma, allergic bronchopulmonary aspergillosis, or vasculitis) * So-called **idiopathic chronic eosinophilic pneumonia**
165
What is Acute eosinophilic pneumonia ?
166
What is Simple pulmonary eosinophilia ?
Simple pulmonary eosinophilia is **characterized by *transient* pulmonary lesions,** eosinophilia in the blood, and a benign clinical course. CT scans are often quite striking, **with shadows of varying size and shape in any of the lobes**, suggesting irregular intrapulmonary densities. The alveolar septa are thickened by an infiltrate composed of eosinophils and occasional interspersed giant cells, but there is no vasculitis, fibrosis, or necrosis.
167
What is Chronic eosinophilic pneumonia ?
Chronic eosinophilic pneumonia is characterized by **focal areas of cellular consolidation of the** **lung substance distributed chiefly in the periphery of the lung fields**. Prominent in these lesions are **heavy aggregates of lymphocytes and eosinophils** within both the septal walls and the alveolar spaces. These patients have **high fever, night sweats, and dyspnea, all of which** respond to **corticosteroid therapy.**
168
SMOKING-RELATED INTERSTITIAL DISEASES
* Desquamative Interstitial Pneumonia * Respiratory Bronchiolitis-Associated Interstitial Lung Disease
169
What is “desquamative interstitial pneumonia.”?
The large collections of airspace macrophages that char-acterize DIP were originally thought to be desquamated pneumocytes, thus the misnomer **“desquamative interstitial pneumonia.”**
170
What is The most striking histologic finding in DIP?
The most striking histologic finding is the **accumulation of a large number of** * *macrophages with abundant cytoplasm containing dusty brown pigment (smokers'** * *macrophages) in the airspaces.** **Finely granular iron may be seen in the macrophage** cytoplasm. Some of the macrophages contain lamellar bodies (composed of surfactant) within phagocytic vacuoles, presumably derived from **necrotic type II pneumocytes**. The **alveolar** * *septa are thickened by a sparse inflammatory infiltrate of lymphocytes, plasma cells, and** * *occasional eosinophils** ( Fig. 15-24 ). The septa are lined by plump, cuboidal pneumocytes. Interstitial fibrosis, when present, is mil]d. Emphysema is often present.
171
FIGURE 15-24 Desquamative interstitial pneumonia. Medium-power detail of lung demonstrates the accumulation of large numbers of macrophages within the alveolar spaces and only mild fibrous thickening of the alveolar walls. DIP
172
DIP usually presents in the **fourth or fifth decade of life,** and is **more common in women** than in men by a ratio of **2 : 1**. **Virtually all patients are cigarette smokers.** **T or F**
DIP usually presents in the **fourth or fifth decade of life,** and is **more common in men** than in women by a ratio of **2 : 1**. ## Footnote **Virtually all patients are cigarette smokers.**
173
What is Respiratory Bronchiolitis-Associated Interstitial Lung Disease ?
Respiratory bronchiolitis is a **common histologic lesion found in cigarette smokers**. It is **characterized by the presence of pigmented intraluminal macrophages within first- and secondorder respiratory bronchioles.** In its mildest form, it is seen most often as an **incidental histologic finding in the lungs of smokers or ex-smokers.** [99] The term respiratory bronchiolitisassociated interstitial lung disease is **ualitiesed for patients who develop significant pulmonary** **symptoms, abnormal pulmonary function, and imaging abnorms.**
174
What is the histological morphology of Respiratory Bronchiolitis-Associated Interstitial Lung Disease
The changes are patchy at low magnification and have a bronchiolocentric distribution. Respiratory bronchioles, alveolar ducts, and peribronchiolar spaces contain **aggregates of dusty brown macrophages (smokers' macrophages)** similar to those seen in DIP. There is a patchy submucosal and peribronchiolar infiltrate of lymphocytes and histiocytes. Mild peribronchiolar fibrosis is also seen, which expands contiguous alveolar septa. Centrilobular emphysema is common but not severe. Histologic overlap with DIP is often found in different parts of the same lung.
175
What are the symptoms of Respiratory Bronchiolitis-Associated Interstitial Lung Disease?
Symptoms are usually mild, **consisting of gradual onset of dyspnea and cough** in patients who are typically current smokers in the fourth or fifth decade of life with average exposures of over 30 pack-years of cigarette smoking. There is a 2 : 1 male predominance. Cessation of smoking usually results in improvement.
176
What is PULMONARY ALVEOLAR PROTEINOSIS?
Pulmonary alveolar proteinosis (PAP) is a **rare disease that is characterized radiologically by bilateral patchy asymmetric pulmonary opacifications**and**histologically by accumulation of acellular surfactant in the intra-alveolar and bronchiolar spaces**
177
PULMONARY ALVEOLAR PROTEINOSIS has three distinct classes of this disease—\_\_\_\_\_\_\_\_\_\_—each with a **different pathogenesis but with a similar spectrum of histologic changes.**
acquired, congenital, and secondary PAP
178
What is acquired PAP?
Acquired PAP **represents 90% of all cases of PAP** and **lacks any familial predisposition.** Unexpectedly, researchers working with knockout mice lacking the gene for the hematopoietic growth factor granulocyte-macrophage colony-stimulating factor (GM-CSF) found that these mice had impaired surfactant clearance by alveolar macrophages, leading to a condition that resembled human PAP.
179
What is the pathophysio of Acquired PAP?
Subsequently, a **GM-CSF–neutralizing autoantibody was found in the** **serum and bronchial fluid of individuals** with acquired PAP that was not present in those with congenital or secondary PAP. Currently, it is thought that the **anti–GM-CSF antibody is** **responsible for the development of the disease**. [100] These antibodies inhibit the activity of endogenous GM-CSF, leading to a state of functional GM-CSF deficiency. The systemic production of the antibody **also provides an explanation for the recurrence of PAP following** **bilateral-lung transplantation.** Thus, acquired PAP is an autoimmune disorder
180
acquired PAP is an autoimmune disorder T or F
True
181
What is congenital PAP?
Congenital PAP is a **rare cause of immediate-onset neonatal respiratory distress.**
182
What is the pathophysiology of congenital PAP
Congenital PAP is a r**are cause of immediate-onset neonatal respiratory distress.** Thus far, **mutations have been identified in multiple genes including those encoding ATP-binding cassette protein member A3 (ABCA3)**(which may be the most frequent),**surfactant protein B (SP-B),** **surfactant protein C (SP-C)**, **GM-CSF, and GM receptor (GM-CSF/IL-3/IL-5) β chain**. **ABCA3** is localized to the lamellar body membrane andis probably involved in transport of surfactant components. [101] **SP-B deficiency** is transmitted in an autosomal recessive manner and is most often caused by a frameshift mutation in the SP-B gene. This leads to an unstable SP-B messenger RNA, reduced or absent SP-B, secondary disturbances of SP-C, and intra-alveolar accumulation of SP-A and SP-C.
183
what is the most frequent mutation inf congenital PAP?
protein member A3 (ABCA3)
184
What is secondary PAP?
Secondary PAP is uncommon. The underlying causes include **hematopoietic disorders,** **malignancies, immunodeficiency disorders, lysinuric protein intolerance, and acute silicosis and other inhalational syndromes.**
185
Whta is the characteristic of PAP?
The disease is characterized by a **peculiar homogeneous, granular precipitate** * *within the alveoli, causing focal-to-confluent consolidation** of large areas of the lungs with * *minimal inflammatory reaction** ( Fig. 15-25 ). On section, turbid fluid exudes from these areas. As a consequence there is a marked increase in the size and weight of the lung. The alveolar precipitate is periodic acid–Schiff positive and also contains cholesterol clefts. Immunohistochemical stains show the presence of surfactant proteins A and C in congenital SP-B deficiency and all three proteins in the acquired form. Ultrastructurally, abnormalities in lamellar bodies in type II pneumocytes can be seen in mutations of SP-B, SP-C, and ABCA3.
186
FIGURE 15-25 Pulmonary alveolar proteinosis, histologic appearance. The alveoli are filled with a dense, amorphous, protein-lipid granular precipitate, while the alveolar walls are normal.
187
What is the presentation of PAP?
Adult patients, for the most part, present with **nonspecific respiratory difficulty of insidious onset,** **cough, and abundant sputum** that often contains chunks of gelatinous material. Some have s**ymptoms lasting for years, often with febrile illnesses.** These patients are at risk for developing **secondary infections with a variety of organisms.** **Progressive dyspnea, cyanosis, and respiratory insufficiency** may occur, but some patients tend to have a benign course, with eventual resolution of the lesions. Whole-lung lavage remains the current standard of care, while GM-CSF therapy is effective in 50% of patients
188
Congenital PAP is a disorder of?
Congenital PAP is a fatal respiratory disorder that is usually immediately apparent in the newborn. Typically, the infant is full term and rapidly develops progressive respiratory distress shortly after birth. Without lung transplantation, death ensues between 3 and 6 months of age.
189
FIGURE 15-22 Characteristic sarcoid noncaseating granulomas, peribronchial, with many giant cells.
190